NuGen Medical Devices Inc.
Loading stock data...
Stock Performance
Price History
-
Drag to select time range
-
Market Data
Market Cap
5.7M
P/E Ratio
-
52-Week High
-
52-Week Low
-
Avg Volume
-
Beta
-
Forward P/E
-
Dividend Yield
-
EV/Revenue
-
Price/Book
-
Business Overview
NuGen Medical Devices Inc., a specialty medical device company, develops and commercializes novel drug delivery technologies in Europe, Asia, North America, Canada, and internationally. The company offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, Vaccines, Veterinary, Home healthcare, and others. It also provides InsuJet that focuses on servicing the diabetic community; and V5, V6, V7, and V8 InsuJet injectors. NuGen Medical Devices Inc. is headquartered in Toronto, Canada.
Healthcare
Medical Devices
TSXV
Key Financial Metrics
1.0M
Revenue
-5.2M
Net Income
C$-0.02
EPS (Diluted)
-4.7M
Free Cash Flow
Profitability
Gross Margin
51.7%
Operating Margin
-510.7%
Net Profit Margin
-517.5%
EBITDA
-2.9M
Returns & Efficiency
Return on Assets (ROA)
-40.5%
Return on Equity (ROE)
-
Dividend Yield
-
Payout Ratio
-
Financial Health
Total Assets
12.9M
Total Debt
17.8M
Debt to Equity
-
Current Ratio
5.84
Company Info
| Industry | Medical Devices |
| HQ | Toronto, Canada |
| Fiscal Year End | 1735603200 |
| Currency | CAD |
| Website | www.nugenmd.com |
Peers
Bausch + Lomb Corporation
BLCO.TO
7.9B
P/E: --
Bausch Health Companies Inc.
BHC.TO
2.5B
P/E: 12.0
Extendicare Inc.
EXE.TO
2.5B
P/E: 23.7
Sienna Senior Living Inc.
SIA.TO
2.2B
P/E: 53.2
Cronos Group Inc.
CRON.TO
1.4B
P/E: 24.1
Tilray Brands, Inc.
TLRY.TO
1.2B
P/E: --
WELL Health Technologies Corp.
WELL.TO
1.1B
P/E: --
Knight Therapeutics Inc.
GUD.TO
631.8M
P/E: --
Insider Activity
Sentiment
Neutral
Shares Bought
0
Shares Sold
0
Total Transactions
2
SEDAR+ Filings
View All Filings5
Annual Reports
17
Quarterly Reports
20
MD&A
69
News Releases
12
Material Changes
3
Prospectuses
6
Governance
39
Certifications
39
Other
●
2025-04-30
●
2023-10-11
●
2023-10-11
●
2023-10-11
●
2020-06-15
●
2021-09-29
●
2019-05-02
●
2019-03-07
Interactive Charts
Company Profile
General Information
| Company Name | NuGen Medical Devices Inc. |
| Ticker | NGMD.V |
| Exchange | TSXV |
| Sector | Healthcare |
| Industry | Medical Devices |
| Headquarters | Toronto, Canada |
| Fiscal Year End | 1735603200 |
| Currency | CAD |
| Website | www.nugenmd.com |
Financial Summary
| Market Cap | 5.7M |
| Revenue | 1.0M |
| Net Income | -5.2M |
| P/E Ratio | N/A |
| EPS (Diluted) | C$-0.02 |
| Net Margin | -517.5% |
| ROE | N/A |
| Dividend Yield | N/A |
Business Description
NuGen Medical Devices Inc., a specialty medical device company, develops and commercializes novel drug delivery technologies in Europe, Asia, North America, Canada, and internationally. The company offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, Vaccines, Veterinary, Home healthcare, and others. It also provides InsuJet that focuses on servicing the diabetic community; and V5, V6, V7, and V8 InsuJet injectors. NuGen Medical Devices Inc. is headquartered in Toronto, Canada.